Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse - Concepedia

Concepedia

Publication | Closed Access

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse

67

Citations

30

References

2014

Year

Thomas Köhnke, Diane Sauter, Katharina Ringel, Eva Hoster, Laubender Rp, M. Hubmann, Bohlander Sk, Kakadia Pm, Simon Schneider, A Dufour,

Hematological MalignancyMedicineHematologyPathologyAplasia Identifies PatientsSurgeryEarly AssessmentOncologyMinimal Residual Disease

References

	Year	Citations

Page 1

Page 1